The Research & Development team at InflaRx is responsible for advancing the company's pipeline of anti-C5a therapies through its stages from discovery to clinical application. This multidisciplinary team conducts preclinical research, drug discovery, pharmacovigilance, and clinical pharmacokinetics to ensure the safety, efficacy, and quality of new therapeutics aimed at treating inflammatory and autoimmune diseases.